Promising Phase 2 ASPEN-06 Study Positions ALX Oncology’s Evorpacept as a Strong ...
Swayampakula Ramakanth, an analyst from H.C. Wainwright, maintained the Buy rating on ALX Oncology Holdings (ALXO – Research Report). The ...